Skip to main content

Division of Hematology and Oncology Archives

Study finds hallmarks of T cell exhaustion within hours of tumor exposure

Aug. 3, 2023—Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional.

Read more


Genomic analysis of SCLC tumors reveals subtypes, offers cues toward personalized treatments

May. 11, 2023—The largest genomic analysis ever conducted of small cell lung cancer tumors (SCLC) has identified genetic subtypes and provided insights into the mechanisms of this aggressive and deadly cancer.

Read more


Vanderbilt mourns loss of former Hematology leader Krantz

Apr. 18, 2023—Sanford Krantz, MD, internationally recognized authority on hematology and erythropoietin and professor of Medicine, Emeritus, died April 13 at his home. He was 89.

Read more


National Cancer Institute honors Berlin’s contributions, leadership

Apr. 6, 2023—Vanderbilt's Jordan Berlin, MD, is a 2022 recipient of the National Cancer Institute Director’s Award.

Read more


New treatment helps mitigate hair loss for chemotherapy patients

Mar. 30, 2023—Vanderbilt-Ingram Cancer Center has started offering scalp cooling, which mitigates hair loss for patients receiving certain chemotherapy regimens.

Read more


Study evaluates polygenic risk score for prostate cancer risk prediction

Mar. 16, 2023—A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.

Read more


Targeted therapy for neuroendocrine tumors

Feb. 16, 2023—Cancer therapies that target VEGF receptor appear safe and effective for patients with pancreatic and non-pancreatic neuroendocrine tumors, meta-analysis of phase 2/3 clinical trials demonstrates.

Read more


Berlin named director of Division of Hematology and Oncology

Feb. 6, 2023—Jordan Berlin, MD, has been named director of Vanderbilt’s Division of Hematology and Oncology.

Read more


New Clinician Spotlight: Muhamed Baljević

Sep. 29, 2022—Specializing in myeloma, amyloidosis and other plasma cell disorders, hematologist and medical oncologist Muhamed Baljević, MD, recently joined Vanderbilt University Medical Center.

Read more


Policy, resources crucial for lung cancer screening: study

Sep. 29, 2022—Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.

Read more


Blood cancer progression

Aug. 29, 2022—Vanderbilt researchers used single-cell technologies to explore the accumulation of mutations during blood cancer progression, which could help identify strategies for preventing leukemia before it occurs.

Read more


Cell-free breast cancer “biopsy”

Aug. 11, 2022—The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more